Hjem › Psoriasisartritt › Maryland
Kliniske studier for Psoriasisartritt i Maryland
7 studier for Psoriasisartritt søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- Klein And Associates M D P A, Hagerstown
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06807424Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Klein & Associates, M.D., P.A., Hagerstown
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Johns Hopkins Bayview Medical Center - Johns Hopkins Asthma & Allergy Center ( Site 5132), Baltimore
- Arthritis and Rheumatism Associates - Rockville ( Site 5127), Rockville
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Baltimore
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- Johns Hopkins Hospital, Baltimore
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Klein and Associates, M.D., P.A., Hagerstown
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07286058Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.